FDA Approves Unknown Drug — WATSON LABS

# FDA Approves Watson Labs Generic Drug Application Watson Labs received FDA approval for abbreviated new drug application ANDA076417 on April 18, 2005, expanding its generic pharmaceutical portfolio and positioning the company to capture market share in an additional therapeutic category. The approval enables Watson Labs to manufacture and distribute a bioequivalent generic alternative, offering cost savings to patients and payers while strengthening the company's competitive position in the competitive generics market.